Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840210 · ClinicalTrials.gov registry record
Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
A clinical trial, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 200,000
- Enrollment target
NCT06840210: Recruiting study, sponsored by Johns Hopkins University.
NCT06840210 is a clinical trial that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06840210 is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 200,000 participants
- Enrollment target
Study Summary
Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-making, and hospital outcomes when used in real-world ED settings. Study Design: The AI tool will be gradually introduced at three hospital EDs: Johns Hopkins Hospital (JHH) Bayview Medical Center (BMC) Howard County General Hospital (HCGH) Before the tool is activated, it will run in the background to collect baseline data without influencing care. Once implemented, doctors will receive training, and researchers will track how often the tool is used and whether it improves AKI care. What the Study Measures: Process Outcomes: Does the tool help doctors identify AKI sooner, avoid harmful medications, and improve decision-making about hospitalization? Clinical Outcomes: Does the tool reduce the number and severity of AKI cases and improve kidney-related health outcomes? Implementation Outcomes: Do ED doctors find the tool useful? Does it fit into the ED doctor's workflow without slowing the ED doctor's down? Expected Impact: If successful, the AI tool could be expanded to other hospitals and used to improve early detection and treatment of AKI, reducing kidney complications and improving patient care nationwide.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2026-03-10 |
| Est. Completion | 2030-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06840210
The ClinicalTrials.gov registry entry for NCT06840210 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06840210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06840210 about?
NCT06840210 is a clinical study titled "Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support". Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-ma...
What is the current status of trial NCT06840210?
This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2026-03-10. Estimated completion is 2030-12-01.
Who is sponsoring clinical trial NCT06840210?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.